Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528020 · ClinicalTrials.gov registry record · NA
Collaborative Adolescent Research on Emotions and Suicide
A NA study of Suicidal and Self-injurious Behaviour, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 173
- Enrollment target
- 1
- Study location
NCT01528020: Completed NA study of Suicidal and Self-injurious Behaviour, sponsored by University of Washington.
NCT01528020 is a NA study of Suicidal and Self-injurious Behaviour that has completed, run by University of Washington. The registered enrollment target is 173 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01528020, a NA study of Suicidal and Self-injurious Behaviour, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
- 1
- Study location
Study Summary
Suicide is the third leading cause of death among adolescents in the US yet there is a paucity of research on effective treatments for this population. The primary aim of the research described in this application is to evaluate the efficacy of dialectical behavior therapy (DBT) for suicidal adolescents. DBT has an empirical track record with suicidal adults of reducing the incidence, frequency and medical risk of suicide attempts and non-suicidal self-injuries among individuals meeting criteria for borderline personality disorder (BPD). While DBT is widely used in the community with suicidal adolescents, particularly those with difficulties characteristic of BPD such as poor emotion regulation and impulse control, no randomized trial of DBT with suicidal adolescents has ever been conducted. And, while non-randomized trials indicate that the intervention is both safe and effective, without a randomized trial the investigators simply do not know whether DBT for suicidal adolescents is efficacious or not. Given the severity of the problem and the lack of alternative treatments for high risk adolescents, addressing this question is of great importance. The second aim of the research is to analyze mediators of reduced suicidal and self-injurious behaviors in adolescents. 170 adolescents at two sites (Seattle and Los Angeles) will be randomized to DBT or Individual and Supportive Group Therapy (IGST). Both treatments include 6 months of individual and group treatment and adolescents and a parent complete 5 assessments over a 1-year period.
Conditions Studied
Interventions
- BEHAVIORAL Dialectical Behavior Therapy
- BEHAVIORAL Individual and Group Supportive Therapy
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT01528020 record still lists
NCT01528020 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Suicidal and Self-injurious Behaviour appearing as the primary indexed condition, and to 2 interventions - of which Dialectical Behavior Therapy is the first listed.
NCT01528020 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01528020 about?
NCT01528020 is a clinical study titled "Collaborative Adolescent Research on Emotions and Suicide". Suicide is the third leading cause of death among adolescents in the US yet there is a paucity of research on effective treatments for this population. The primary aim of the research described in this application is to evaluate the efficacy of dialectical behavior therapy (DBT) for suicidal adolesc...
What is the current status of trial NCT01528020?
This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2012-01. Estimated completion is 2016-05.
What conditions does trial NCT01528020 study?
This clinical trial studies the following conditions: Suicidal and Self-injurious Behaviour.
What interventions are being tested in trial NCT01528020?
The interventions under investigation include: Dialectical Behavior Therapy (BEHAVIORAL), Individual and Group Supportive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01528020?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01528020 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01528020's enrollment target sits among peer trials
173 611th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia